AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,650.00p
   
  • Change Today:
    196.00p
  • 52 Week High: 12,666.71p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.70m
  • Volume: 2,123,552
  • Market Cap: £196,164m
  • RiskGrade: 123
  • Beta: 0.00

Latest ShareCast News

London midday: UK stocks keep grinding towards year's highs

By Alexander Bueso

Date: Friday 03 Oct 2025

(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the ongoing budget standoff in Washington D.C..

AstraZeneca ShareCast News

Trump's MFN deal with Pfizer could be bellwether... 01-Oct-2025 ShareCast
AstraZeneca to list in New York, retain London l... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast
EU approves AstraZeneca's Tezspire to treat nasa... 22-Sep-2025 ShareCast
London close: Stocks mixed ahead of central bank... 15-Sep-2025 ShareCast

AstraZeneca Regulatory News

Total Voting Rights 01-Oct-2025 15:00 RNS
Enhertu improved IDFS in early BC in DB-05 29-Sep-2025 07:30 RNS
AZN harmonises listing structure 29-Sep-2025 07:00 RNS
Director/PDMR Shareholding 25-Sep-2025 16:30 RNS
Koselugo recommended for EU approval 22-Sep-2025 07:05 RNS

AstraZeneca Newspaper Links

AstraZeneca plans direct US listing in blow to L... 29-Sep-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,650.00p
Change Today 196.00p
% Change 1.57 %
52 Week High 12,666.71p
52 Week Low 9,667.00p
Volume 2,123,552
Shares Issued 1,550.70m
Market Cap £196,164m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 03-Oct-2025

Time Volume / Share Price
16:09 0 @ 12,600.00p
15:50 0 @ 12,620.00p
15:45 5 @ 12,636.00p
15:45 5 @ 12,640.00p
15:55 0 @ 12,590.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page